EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

Personalized versus generic digital weight loss interventions delivered on university campuses: a 6-month cost-benefit analysis

Melissa A Napolitano iD, Caitlin P Bailey iD, Meghan N Mavredes, Charles J Neighbors, Jessica A Whiteley, Michael W Long, Laura L Hayman, Steven K Malin, Loretta DiPietro

Translational Behavioral Medicine · 2023

DOI: 10.1093/tbm/ibac081 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Translational Behavioral Medicine, 2023. Verfasst von Melissa A Napolitano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Weight Reduction Programs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cost-effectiveness analyses of weight loss programs for university students can inform administrator decision-making. This study quantifies and compares the costs and cost-effectiveness of implementing two digitally-delivered weight loss interventions designed for university populations. Healthy Body Healthy U (HBHU) was a randomized controlled trial comparing TAILORED (personalized) versus TARGETED (generic) weight loss interventions adapted specifically for young adults to a CONTROL intervention. Participants (N = 459; 23.3 ± 4.4 years; mean BMI 31.2 ± 4.4 kg/m2) were recruited from two universities. Implementation costs were examined from a payer (i.e., university) perspective, comparing both the average cost effectiveness ratio (ACER) and the incremental cost effectiveness ratio (ICER) of the two interventions. Cost-effectiveness measures were calculated for changes in body weight, abdominal circumference, HDL cholesterol, systolic and diastolic blood pressure, and HbA1c. The overall 6-month implementation costs were $105.66 per person for the TAILORED intervention and $91.44 per person for the TARGETED intervention. The ACER for weight change was $107.82 for the TAILORED and $179.29 for the TARGETED interventions. The ICER comparing TAILORED with TARGETED for change in body weight was $5.05, and was even lower ($2.28) when including only those with overweight and not obesity. The ICERs for change in abdominal circumference, HDL cholesterol, systolic and diastolic blood pressure, and HbA1c were $3.49, $59.37, $1.57, $2.64, and $47.49, respectively. The TAILORED intervention was generally more cost-effective compared with the TARGETED intervention, particularly among those with overweight. Young adults with obesity may require more resource-intensive precision-based approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisWeight Reduction ProgramsHumansMaleFemaleUniversitiesYoung AdultAdultStudentsWeight LossObesity

Stichwörter der Autor:innen

costcost effectivenessinterventiontailoredweight lossyoung adult

Autor:innen und Institutionen

  • Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
  • Department of Population Health, Grossman School of Medicine, New York University, New York, NY, USA.
  • Departmen of Exercise and Health Sciences, College of Nursing and Health Sciences, The University of Massachusetts at Boston, Boston, MA, USA.
  • Department of Nursing, College of Nursing and Health Sciences, The University of Massachusetts at Boston, Boston, MA, USA.
  • Department of Kinesiology and Division of Endocrinology, Metabolism and Nutrition, Rutgers University, New Brunswick, NJ, USA.

ORCID-Profile: Melissa A Napolitano, Caitlin P Bailey

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Napolitano, M. A., Bailey, C. P., Mavredes, M. N., Neighbors, C. J., Whiteley, J. A., Long, M. W., Hayman, L. L., Malin, S. K., & DiPietro, L. (2023). Personalized versus generic digital weight loss interventions delivered on university campuses: a 6-month cost-benefit analysis. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibac081

Vancouver

Napolitano MA, Bailey CP, Mavredes MN, Neighbors CJ, Whiteley JA, Long MW, et al. Personalized versus generic digital weight loss interventions delivered on university campuses: a 6-month cost-benefit analysis. Translational Behavioral Medicine. 2023. doi:10.1093/tbm/ibac081

BibTeX
@article{Napolitano2023,
  author = {Napolitano, Melissa A and Bailey, Caitlin P and Mavredes, Meghan N and Neighbors, Charles J and Whiteley, Jessica A and Long, Michael W and Hayman, Laura L and Malin, Steven K and DiPietro, Loretta},
  title = {Personalized versus generic digital weight loss interventions delivered on university campuses: a 6-month cost-benefit analysis},
  journal = {Translational Behavioral Medicine},
  year = {2023},
  doi = {10.1093/tbm/ibac081}
}
Kostenlos starten →